SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-002887
Filing Date
2021-05-06
Accepted
2021-05-06 10:36:31
Documents
2
Period of Report
2021-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K insd_8k.htm 8-K 16142
2 AMENDMENT TO LETTER OF INTENT insd_ex101.htm EX-10.1 14355
  Complete submission text file 0001477932-21-002887.txt   31727
Mailing Address 1545 CROSSWAYS BLVD. SUITE 250 CHESAPEAKE VA 23320-0218
Business Address 1545 CROSSWAYS BLVD. SUITE 250 CHESAPEAKE VA 23320-0218 800-542-8715
Instadose Pharma Corp. (Filer) CIK: 0001697587 (see all company filings)

IRS No.: 813599639 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 333-216292 | Film No.: 21896351
SIC: 2510 Household Furniture